A detailed history of Huntleigh Advisors, Inc. transactions in Lensar, Inc. stock. As of the latest transaction made, Huntleigh Advisors, Inc. holds 77,796 shares of LNSR stock, worth $942,887. This represents 0.2% of its overall portfolio holdings.

Number of Shares
77,796
Previous 75,685 2.79%
Holding current value
$942,887
Previous $1.07 Billion 4.13%
% of portfolio
0.2%
Previous 0.25%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 29, 2025

BUY
$12.22 - $14.18 $25,796 - $29,933
2,111 Added 2.79%
77,796 $1.02 Billion
Q1 2025

Apr 29, 2025

BUY
$7.66 - $16.87 $579,747 - $1.28 Million
75,685 New
75,685 $1.07 Billion

Others Institutions Holding LNSR

About LENSAR, Inc.


  • Ticker LNSR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 11,021,000
  • Market Cap $134M
  • Description
  • LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in...
More about LNSR
Track This Portfolio

Track Huntleigh Advisors, Inc. Portfolio

Follow Huntleigh Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntleigh Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Huntleigh Advisors, Inc. with notifications on news.